Long-term Alterations of Host-microbiome Interactions and Cardiovascular and Respiratory Diseases Progression After Pneumonia
Condition(s) studied
Investigational drug(s) / intervention(s)
Blood samples: Four blood samples will be taken outside standard care for groups A, B, C and D: at inclusion, M6 and M18 (only at inclusion for group C).
Oropharyngeal swabs: An oropharyngeal swab will be taken to analyze patients\' upper airway microbiome at inclusion, M6 and M18.
ECG: Performed at inclusion, M6 and M18
Cardiopulmonary exercise test, spirometry, plethysmography, pulmonary absorption of carbon monoxide in a single inspiration: Cardiopulmonary exercise test, spirometry, plethysmography, pulmonary absorption of carbon monoxide in a single inspiration: These tests will be performed consecutively for 2 hours at inclusion M6 and M18. These tests will be performed to assess respiratory and cardiac function.
Study summary
The HOMI-LUNG - HAP study is part of the HOMI-LUNG project, funded by the Horizon Europe program. The "HOMI-LUNG" project is an international, interdisciplinary project that aims to better understand the causal links between respiratory tract infections (i.e. pneumonia) and the progression of cardiovascular disease. More specifically, the project aims to quantify the burden of cardiovascular disease after pneumonia and assess patients; acceptability of long-term health alterations, as well as to define pneumonia endotypes with distinct pathobiological mechanisms associated with exacerbation of cardiovascular disease.
Eligibility
Primary outcome measure(s)
- Major adverse cardiovascular events (MACE) — 6 months
Major adverse cardiovascular events (MACE) at 6 months
Trial sites (5)
| Facility | City | Region | Status |
|---|---|---|---|
| Angers University Hospital | Angers | France | Not Yet Recruiting |
| Nantes University Hospital | Nantes | France | Recruiting |
| Rennes University Hospital | Rennes | France | Not Yet Recruiting |
| Rouen University Hospital | Rouen | France | Not Yet Recruiting |
| Toulouse University Hospital | Toulouse | France | Not Yet Recruiting |
More Nantes University Hospital trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06602934 on ClinicalTrials.gov ↗ ← All trials in France